Metabotropic glutamate receptors are a heterogeneous family of G-protein-co
upled receptors that are linked to multiple second messenger systems to reg
ulate neuronal excitability and synaptic transmission. To elucidate the phy
siological role of these receptors in human central nervous system function
and dysfunction at the receptor protein level requires the use of selectiv
e antibodies to determine the phenotype of cells expressing particular rece
ptor subtypes. To this end the present study has examined the regional and
cellular localization of the metabotropic glutamate type 2 receptor protein
in selected human brain regions. After epitope prediction, antibodies have
been generated against a short synthetic peptide corresponding to amino ac
id residues located in the putative intracellular carboxy-terminus and subs
equently applied to an immunohistochemical investigation. Antibodies specif
ically detected the type 2 receptor in transfected mammalian cells and also
recognized a major band of 98,000 mol. wt in western blots of human brain
tissue membranes. At the light microscope level immunohistochemical studies
have demonstrated that type 2-like immunoreactivity was widely distributed
in the human brain, being characterized by the presence of a strong immuno
reaction in multiple cortical regions, and in structures comprising the bas
al ganglia, to include the caudate nucleus, putamen, globus pallidus, subst
antia nigra and subthalamic nucleus. In the hippocampal formation, immunore
activity was predominant in selective cell layers of both the dentate gyrus
and cornu ammonia, the subicular complex and entorhinal cortex. In the tha
lamus, multiple subnuclei showed reaction product. In the cerebellar cortex
, immunoreactivity was expressed in a number of cell layers and cell types.
Furthermore, using double immunofluorescence we confirmed that the type 2
receptor is a product of normal resting astrocytes in the cerebral cortex i
n particular.
This antibody provides a new immunological tool with the potential to evalu
ate the distribution of human metabotropic glutamate receptor 2 protein in
other brain regions and in human central nervous system diseases. (C) 1999
IBRO. Published by Elsevier Science Ltd.